Summary
Определение
Анамнез и осмотр
Ключевые диагностические факторы
- presence of risk factors
- lesion growth over weeks to months
- round, raised papule
- tiny black dots on surface of lesion
Другие диагностические факторы
- satellite lesions
- fingers or nail fold lesions
- facial lesions
- fissuring
- hyperkeratosis
- grayish-white or light brown color
- filiform papule with sharp spikes
Факторы риска
- water immersion
- occupations involving handling of meat or fish
- nail biting
- age under 35 years
- immunocompromised
Диагностические исследования
Исследования, которые показаны в первую очередь
- no initial test
Исследования, проведение которых нужно рассмотреть
- skin biopsy
- immunoperoxidase stain
- skin culture
Алгоритм лечения
common wart: immunocompetent
common wart: immunocompromised
filiform wart
Составители
Авторы
Angela Yen Moore, MD
Director
Arlington Center of Dermatology
Primary Investigator
Arlington Research Center
Arlington
Clinical Assistant Professor
Baylor University Medical Center
Dallas
Clinical Assistant Professor
University of Texas Medical Branch
Galveston
TX
Раскрытие информации
Dr. Moore receives funds as an advisory board member (A), consultant (C), clinical study investigator (I), and speaker (SP) – for Abbvie (I,SP), Almirall (C,I,SP), Arcutis (I), Biofrontera (C,I), Boehringer Ingelheim (I), Bristol-Myers Squibb (C,I), Dermavant (I), DS Biopharma (I), Eli Lilly (I), EpiHealth (A), Evolus (A), Galderma (I), Incyte (I), Janssen (I), Leo (A,SP), Mayne Pharma (C,I), Nimbus (I), Novartis (I), Parexel (I), Pfizer (I,SP), UCB (I), Verrica (I), Vyne (I,SP).
Выражение благодарностей
Dr Angela Yen Moore would like to gratefully acknowledge Dr Leonid Izikson, the previous contributor to this topic. LI declares that he has no competing interests.
Рецензенты
Brenda L. Pellicane, MD
Dermatologist
Wayne State University School of Medicine
Department of Dermatology
Detroit
MI
Раскрытие информации
BLP declares that she has no competing interests.
David Cassarino, MD, PhD
Assistant Professor
Department of Pathology and Laboratory Medicine
University of California
Los Angeles
CA
Раскрытие информации
DC declares that he has no competing interests.
Jashin J. Wu, MD
Chief Dermatology Resident
University of California
Irvine
CA
Раскрытие информации
JJW declares that he has no competing interests.
Sam Gibbs, FRCP
Consultant Dermatologist
Dermatology Department
The Great Western Hospital
Swindon
UK
Раскрытие информации
SG declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Список литературы
Основные статьи
Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006;4:273-293.Полный текст Аннотация
Gibbs S, Harvey I, Sterling J, et al. Local treatments for cutaneous warts: systematic review. BMJ. 2002;325:461.Полный текст Аннотация
Kwok CS, Gibbs S, Bennett C, et al. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012;(9):CD001781.Полный текст Аннотация
Dall'oglio F, D'Amico V, Nasca MR, et al. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012;13:73-96. Аннотация
Статьи, указанные как источники
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Отличия
- Flat warts
- Palmoplantar warts
- Seborrheic keratosis
Больше ОтличияРекомендации
- Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV
- Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV
Больше РекомендацииЛифлеты для пациента
Warts
HPV (human papillomavirus) vaccine
Больше Лифлеты для пациентаВойдите в учетную запись или оформите подписку, чтобы получить полноценный доступ к BMJ Best Practice
Использование этого контента попадает под действие нашего заявления об отказе от ответственности